Used in pharmaceutical research as a key intermediate in the synthesis of centrally acting agents targeting neurological disorders. Shows affinity for monoaminergic receptors, making it valuable in developing compounds for cognitive enhancement and mood regulation. Investigated for potential use in treating attention deficit disorders and depression due to its structural properties that support blood-brain barrier penetration. Also employed in structure-activity relationship (SAR) studies to optimize pharmacokinetic profiles of novel therapeutics.